Day: January 5, 2024

CAMBRIDGE, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Allan Reine, M.D., as the Company’s Chief Financial Officer, effective January 17, 2024. A seasoned financial executive with over twenty years’ experience in the biotechnology industry, Dr. Reine will be responsible for the company’s financing strategy and investor relations, and will oversee all financial operations as Prime Medicine begins its transition into a clinical company. “I am delighted to welcome Allan to Prime Medicine. He brings tremendous financial, operational and leadership experience in the life sciences space, as well as a proven track record developing and implementing multi-pronged...

Acquisition Expected to Contribute More than $8 Million of Annualized Revenue and Positive Net Income MIAMI, Jan. 05, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has completed the audit for the planned acquisition of a premier eCommerce nutraceuticals company with operations in North America. The acquisition is expected to close within the next several weeks and is subject to financing and customary closing conditions. “We have now completed the audit for our acquisition and expect to close in early 2024,” stated Darren Minton, CEO of Smart for Life. “Once closed, this will be one of our largest acquisitions since going...

Vancouver, Canada, Jan. 05, 2024 (GLOBE NEWSWIRE) —  WestKam Gold Corp. (TSX-V:WKG)(the “Company” or “WestKam”) wishes to advise that the acquisition of the McConnell Property in British Columbia has been terminated. Under the terms of the definitive agreement (see prior news releases dated December 11, 2023 and July 24, 2023), the Company had until December 31, 2023 to meet all conditions precedent unless an extension was mutually agreed upon by all parties. The terms of the agreement required TSV-V approval of the transaction which included a concurrent financing, as well as issuance of a number of common shares that would result in the vendor holding a 19.99% interest in the Company as of the closing date after giving effect to the issuance of these shares. The parties to the agreement were unable to conclude negotiations on...

Portage, Michigan, Jan. 05, 2024 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker – Press Releases that day. The press release will include summary financial information for the company’s fourth quarter and full year 2023, that ended December 31, 2023. Stryker will host a webcast at 4:30pm ET on Tuesday, January 30, 2024, to discuss results for its fourth quarter and full year 2023.  The webcast can be accessed at Stryker – Events & Presentations.  An archive of the webcast will also be available on the company’s website two hours after the live call ends. About Stryker Stryker is one of the world’s leading medical technology...

ReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 05, 2024 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that it has received payment from Noridian Healthcare Solutions (“Noridian”), a Medicare Administrative Contractor (“MAC”), for its first claim for the ReWalk Personal Exoskeleton. This marks coverage and payment by Medicare fee-for-service for the first-ever claim submitted for a ReWalk Personal Exoskeleton device. This milestone reflects an acknowledgement by Medicare that the ReWalk Personal...

MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness, and serious disease, advises that it has received formal notice from the Nasdaq Stock Market, LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). As previously disclosed, the Company received a written notice from Nasdaq on July 17, 2023, notifying the Company that it had failed to meet the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Capital Market. To regain compliance with the Listing Rule, the Company’s American Depositary Shares (ADS) were required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive...

Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore receives amendment and waiver for its term debt facility with Alcon and BMO CHASKA, Minn., Jan. 05, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has finalized a series of updated commercial arrangements with its long-term commercial Hyaluronic Acid and CDMO customer, Alcon (SIX/NYSE: ALC) (Alcon) to extend and expand the existing CDMO relationship. Additionally, the Company also entered into a limited waiver and amendment to its credit agreements with Alcon and with BMO to, among other things, waive certain financial reporting delivery requirements....

Howard Hughes Communities Distinguished by Strong New Home SalesSummerlin®, a Howard Hughes Community in Las Vegas, NevadaSummerlin® ranks #4 on RCLCO’s national list of top-selling master planned communities for 2023Bridgeland®, a Howard Hughes Community in the Greater Houston, Texas areaBridgeland® ranks #5 on RCLCO’s national list of top-selling master planned communities for 2023THE WOODLANDS, Texas, Jan. 05, 2024 (GLOBE NEWSWIRE) — Summerlin® and Bridgeland®, two of the award-winning communities in the Howard Hughes Holdings Inc. (NYSE: HHH) portfolio, have been ranked among the nation’s top five best-selling master planned communities (MPCs) for 2023, according to the year-end report released by national real estate consultant RCLCO. Summerlin, in Las Vegas, Nevada, ranked #4 on the RCLCO list with a 39%...